Eisai Overview

  • Founded
  • 1941

Founded
  • Status
  • Public

  • Employees
  • 11,322

Employees
  • Stock Symbol
  • 4523

Stock Symbol
  • Investments
  • 16

  • Share Price
  • $45.08

  • (As of Wednesday Closing)

Eisai General Information

Description

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Contact Information

Website
www.eisai.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • 4-6-10 Koishikawa
  • Bunkyo-ku
  • Tokyo, 112-8088
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eisai Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$45.08 $45.23 $37.52 - $85.58 $12.9B 287M 993K $1.49

Eisai Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 12,052,928 12,052,928 18,501,938 20,319,378
Revenue 6,731,388 6,731,388 6,091,522 6,397,545
EBITDA 820,227 820,227 823,071 1,464,162
Net Income 426,853 426,853 395,532 1,119,877
Total Assets 10,154,327 10,154,327 9,866,482 9,827,981
Total Debt 777,506 777,506 814,871 832,206
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Eisai Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eisai‘s full profile, request access.

Request a free trial

Eisai Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical
Pharmaceuticals
Tokyo, Japan
11,322 As of 2022
0000

000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
000000000000000
Mumbai, India
00 As of 0000
00.000
00000000000 00.000

000000

lor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
000000000000000
Lagos, Nigeria
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eisai Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis India Corporation Mumbai, India 00 00.000 00000000000 00.000
000000000000000 00 Corporation Lagos, Nigeria 00
000000 00000 Corporation Mumbai, India 0000
00000000 Corporation Basel, Switzerland 000000 000000000000
000000 00000000000 Corporation Tokyo, Japan 00000 00000000
To view Eisai’s complete competitors history, request access »

Eisai Patents

Eisai Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220017517-A1 Substituted piperidine compounds and their use Pending 17-Jul-2020 0000000000
US-20220081486-A1 Anti-bcma antibody-drug conjugates and methods of use Pending 05-Jun-2020 00000000000
EP-3868838-A2 Fluorescent dye and use thereof Pending 03-Feb-2020 0000000000
JP-2021123624-A Fluorescent dye and use thereof Pending 03-Feb-2020 0000000000
US-20210255191-A1 Fluorescent dye and use thereof Pending 03-Feb-2020 C07F7/0816
To view Eisai’s complete patent history, request access »

Eisai Executive Team (8)

Name Title Board Seat Contact Info
Yuji Matsue President & Chief Executive Officer
Ivan Cheung Chief Executive Officer & Chairman
Haruo Naito Chief Executive Officer & Board Member
Shaji Procida Chief Operating Officer, President and Commercial Head of the Oncology Business Group, Americas
Kazumasa Nagayama Chief Strategy Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Eisai Board Members (13)

Name Representing Role Since
00000 0000000 Eisai Board Member 000 0000
00000000 000 Eisai Board Member 000 0000
00000 00000 Eisai Chief Executive Officer & Board Member 000 0000
000000 0000000 Eisai Board Member 000 0000
0000 000000 Eisai Chief Executive Officer & Chairman 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Eisai Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eisai Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eisai‘s full profile, request access.

Request a free trial

Eisai Investments & Acquisitions (16)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Apr-2022 0000000000 Medical Records Systems
00000000 0000 27-Jan-2022 00000 0000 000.00 Drug Discovery
000000000 000 09-Sep-2021 00000 0000 0000 Therapeutic Devices
Ō000 000000 01-Jun-2021 00000 0000 00000 Monitoring Equipment
Allm (Healthcare Technology Systems) 05-Apr-2021 Later Stage VC 000.00 Other Healthcare Technology Systems
You’re viewing 5 of 16 investments and acquisitions. Get the full list »

Eisai Subsidiaries (2)

Company Name Industry Location Founded
Eisai Ventures Corporate Venture Capital Tokyo, Japan 2019
00000000 Medical Records Systems Tokyo, Japan 0000
To view Eisai’s complete subsidiaries history, request access »

Eisai Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 (0000000000 0 05-Apr-2021 00000 00000 00 000.00 Completed
  • 20 buyers
00000 06-Jan-2010 000000000000000000 00000 Completed
  • 00000
00000 01-Oct-2007 0000 000.00 Completed
  • 00000
EIDIA 18-Oct-1990 Merger/Acquisition 000.00 Completed
To view Eisai’s complete exits history, request access »